Covovax gets DCGI’s EUA nod for 12-17-year-olds


In a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year olds. This is the fourth vaccine to get regulatory approval for use in youngsters.